NasdaqGM - Nasdaq Real Time Price USD
Entrada Therapeutics, Inc. (TRDA)
8.62
-0.09
(-1.03%)
As of 9:41:22 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 303,334 | 7 |
| Sales | 99,362 | 7 |
| Net Shares Purchased (Sold) | 203,972 | 14 |
| Total Insider Shares Held | 6.24M | -- |
| % Net Shares Purchased (Sold) | 3.40% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| WENTWORTH KORY JAMES Chief Financial Officer | Conversion of Exercise of derivative security at price 2.10 per share. | Direct | 23,381 | Apr 3, 2025 |
| WENTWORTH KORY JAMES Chief Financial Officer | Sale at price 10.67 per share. | Direct | 19,035 | Mar 17, 2025 |
| DOSHI DIPAL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| WENTWORTH KORY JAMES Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| DOWDEN NATHAN J President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| SETHURAMAN NATARAJAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 28, 2025 |
| MPM BIOVENTURES III, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 20.23 - 20.77 per share. | Indirect | 917,111 | Dec 11, 2024 |
| SETHURAMAN NATARAJAN Officer | Sale at price 20.00 - 20.26 per share. | Direct | 320,620 | Dec 3, 2024 |
| WENTWORTH KORY JAMES Chief Financial Officer | Sale at price 19.97 - 20.00 per share. | Direct | 119,948 | Dec 2, 2024 |
| WENTWORTH KORY JAMES Chief Financial Officer | Conversion of Exercise of derivative security at price 2.10 per share. | Direct | 12,600 | Dec 2, 2024 |
| SETHURAMAN NATARAJAN Officer | Sale at price 20.01 - 20.04 per share. | Direct | 82,300 | Nov 13, 2024 |
| WENTWORTH KORY JAMES Chief Financial Officer | Sale at price 19.98 per share. | Direct | 172,562 | Nov 11, 2024 |
| WENTWORTH KORY JAMES Chief Financial Officer | Conversion of Exercise of derivative security at price 2.10 per share. | Direct | 12,600 | Nov 11, 2024 |
| SETHURAMAN NATARAJAN Officer | Sale at price 18.02 - 19.32 per share. | Direct | 339,281 | Nov 6, 2024 |
| SETHURAMAN NATARAJAN Officer | Sale at price 18.00 per share. | Direct | 10,800 | Oct 16, 2024 |
| DOWDEN NATHAN J President | Sale at price 16.00 per share. | Direct | 13,552 | Sep 26, 2024 |
| WENTWORTH KORY JAMES Chief Financial Officer | Sale at price 14.97 per share. | Direct | 47,832 | Sep 9, 2024 |
| DOWDEN NATHAN J President | Sale at price 15.07 - 15.19 per share. | Direct | 34,753 | Sep 9, 2024 |
| SETHURAMAN NATARAJAN Officer | Sale at price 15.09 - 15.24 per share. | Direct | 49,004 | Sep 9, 2024 |
| DOWDEN NATHAN J President | Sale at price 16.26 - 16.70 per share. | Direct | 440,801 | Aug 16, 2024 |
| DOWDEN NATHAN J President | Conversion of Exercise of derivative security at price 1.74 per share. | Direct | 34,800 | Aug 16, 2024 |
| DOSHI DIPAL Chief Executive Officer | Sale at price 17.81 - 18.00 per share. | Direct | 33,897 | Jul 15, 2024 |
| SETHURAMAN NATARAJAN Officer | Sale at price 18.00 per share. | Direct | 22,284 | Jul 15, 2024 |
| WENTWORTH KORY JAMES Chief Financial Officer | Sale at price 14.95 per share. | Direct | 26,282 | Jul 8, 2024 |
| DOSHI DIPAL Chief Executive Officer | Sale at price 16.17 per share. | Direct | 16,174 | Jun 13, 2024 |
| KIM PETER S Director | Conversion of Exercise of derivative security at price 6.06 per share. | Direct | 72,223 | Jun 3, 2024 |
| SETHURAMAN NATARAJAN Officer | Sale at price 15.00 - 15.19 per share. | Direct | 287,695 | May 20, 2024 |
| DOSHI DIPAL Chief Executive Officer | Sale at price 15.00 - 15.11 per share. | Direct | 45,129 | May 17, 2024 |
| KIM PETER S Director | Purchase at price 14.59 per share. | Direct | 364,672 | May 14, 2024 |
| KIM PETER S Director | Purchase at price 14.04 - 14.25 per share. | Direct | 63,306 | May 9, 2024 |
| KIM PETER S Director | Purchase at price 13.57 per share. | Direct | 35,290 | Apr 8, 2024 |
| KIM PETER S Director | Purchase at price 13.75 per share. | Direct | 20,794 | Mar 28, 2024 |
| KIM PETER S Director | Purchase at price 13.36 - 13.76 per share. | Direct | 122,882 | Mar 26, 2024 |
| KIM PETER S Director | Purchase at price 12.66 - 13.24 per share. | Direct | 34,996 | Mar 21, 2024 |
| WENTWORTH KORY JAMES Chief Financial Officer | Conversion of Exercise of derivative security at price 2.10 per share. | Direct | 18,900 | Mar 15, 2024 |
| WENTWORTH KORY JAMES Chief Financial Officer | Sale at price 12.31 per share. | Direct | 50,285 | Mar 6, 2024 |
| DOWDEN NATHAN J President | Sale at price 12.32 per share. | Direct | 22,499 | Mar 6, 2024 |
| DOSHI DIPAL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| WENTWORTH KORY JAMES Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| DOWDEN NATHAN J President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| SETHURAMAN NATARAJAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| DOSHI DIPAL Chief Executive Officer | Sale at price 15.00 per share. | Direct | 15,000 | Feb 15, 2024 |
| DOSHI DIPAL Chief Executive Officer | Sale at price 15.99 per share. | Direct | 15,990 | Jan 16, 2024 |
| WENTWORTH KORY JAMES Chief Financial Officer | Sale at price 15.07 - 16.67 per share. | Direct | 194,845 | Dec 26, 2023 |
| WENTWORTH KORY JAMES Chief Financial Officer | Conversion of Exercise of derivative security at price 2.10 per share. | Direct | 26,250 | Dec 26, 2023 |
| DOSHI DIPAL Chief Executive Officer | Sale at price 15.00 per share. | Direct | 15,000 | Dec 20, 2023 |
| DOSHI DIPAL Chief Executive Officer | Sale at price 16.23 per share. | Direct | 16,230 | Nov 13, 2023 |
| DOSHI DIPAL Chief Executive Officer | Sale at price 15.00 per share. | Direct | 15,000 | Oct 17, 2023 |
| DOSHI DIPAL Chief Executive Officer | Sale at price 15.00 per share. | Direct | 15,000 | Sep 13, 2023 |
| WENTWORTH KORY JAMES Chief Financial Officer | Sale at price 13.45 - 14.03 per share. | Direct | 12,806 | Sep 6, 2023 |
Related Tickers
SYBX Synlogic, Inc.
1.1536
+3.00%
AURA Aura Biosciences, Inc.
5.74
-0.35%
ACRV Acrivon Therapeutics, Inc.
1.9300
-3.52%
TYRA Tyra Biosciences, Inc.
9.93
-0.90%
0RA.F RAPT Therapeutics, Inc.
0.7500
+7.14%
38I.DU Intellia Therapeutics Inc
7.01
-4.05%
1U5.SG Wave Life Sciences Ltd.
5.85
-4.88%
ADXN.SW Addex Therapeutics Ltd
0.0506
-4.89%
PMVP PMV Pharmaceuticals, Inc.
1.0600
-0.93%
SYRE Spyre Therapeutics, Inc.
14.39
+1.20%